Literature DB >> 35885527

Osteosarcoma Arising in Fibrous Dysplasia of the Long Bone: Characteristic Images and Molecular Profiles.

Han Gyeol Kim1, Jong Hun Baek2, Kiyong Na3.   

Abstract

Fibrous dysplasia (FD) is a benign fibro-osseous lesion that frequently involves the craniofacial bones and femur. Malignant transformation of FD is a rare occurrence. We report a 38-year-old woman with osteosarcoma (OS) arising from FD of the femur. Magnetic resonance imaging revealed a well-defined lesion in the medulla of the femur, with cortical thinning and local bone destruction. Wide excision of the femur was performed. Grossly, the inner part of the mass was hard and tan-gray in color, and the outer part of the mass adjacent to the cortex showed myxoid discoloration with infiltrative borders. Microscopically, most of the tumor consisted of curvilinear woven bone and fibrous stroma with bland spindle cells, which transitioned to the outer portion of the tumor, showing cellular proliferation of pleomorphic cells with frequent mitotic activity. Next-generation sequencing revealed GNAS and TP53 mutations, and the diagnosis of OS arising from FD was strongly supported. This case highlights the characteristic images and molecular features of the malignant transformation of FD.

Entities:  

Keywords:  fibrous dysplasia; malignant transformation; next-generation sequencing; osteosarcoma

Year:  2022        PMID: 35885527      PMCID: PMC9323252          DOI: 10.3390/diagnostics12071622

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


Fibrous dysplasia (FD) is a benign fibro-osseous lesion with varying proportions of fibrous and osseous components. Depending on whether FD affects one or multiple bones, it is divided into monostotic and polyostotic types [1]. The craniofacial bones and femur are commonly involved in monostotic FD [2]. Malignant transformation of FD rarely occurs, and osteosarcoma (OS) is the most common histological subtype [3,4]. To date, there have been few reports demonstrating the molecular profiles of OS in FD [5]. Herein, we describe the clinicopathological, immunohistochemical, and molecular features of OS arising from FD of the proximal femur in a middle-aged woman. A detailed case presentation is presented in Figure 1 and Figure 2. As the degree of nuclear atypia and tumor cellularity in the outer portion suggested high-grade OS, we considered dedifferentiated low-grade central osteosarcoma (LGCOS) and OS arising in FD as the main differential diagnoses. LGCOS can be differentiated from FD by the presence of the following histologic features: infiltrative growth, cellularity, cytologic atypia, and mitotic activity [6,7]. Infiltrative growth, such as permeation or extension to the cortical bone and adjacent soft tissue, is an important gross feature of LGCOS. Microscopically, increased cellularity and intersecting fascicular patterns of spindle cells are usually detected in LGCOS but not in FD. LGCOS shows focal nuclear atypia, including hyperchromatic, enlarged nuclei, and irregular nuclear membranes. In addition to the morphological features, investigation of the underlying molecular profiles is helpful for differential diagnosis. While FD frequently harbors GNAS mutations [8,9], LGCOS frequently shows MDM2 and/or CDK4 amplification [10]. We conducted next-generation sequencing (NGS) analysis to determine whether the high-grade OS was dedifferentiation from LGCOS or malignant transformation from FD. DNA sequence-change analysis revealed GNAS (p.R201H, c.602G > A) and TP53 mutations (p.W53Cfs*70, c.159delG). Copy number variation analysis revealed a gain of PDGFRA, KIT, and CTNND2 and a loss of CDKN2A. TP53 mutations and CDKN2A deletions have been reported in primary OS or secondary OS associated with FD [5,11]. Our NGS results strongly supported the diagnosis of malignant transformation of FD. Following surgical resection and pathological diagnosis, the patient underwent Adriamycin-based chemotherapy and was alive without evidence of disease recurrence for 6 months. This case highlights the macroscopic, microscopic, and molecular characteristics of the malignant transformation of FD into OS. The diagnostic approaches, characteristic images, and interpretations of ancillary tests demonstrated in this case would help pathologists and clinicians make accurate diagnoses of malignant transformation of FD and their differential diagnosis from dedifferentiated LGCOS, which is essential for establishing an optimal treatment plan. A 38-year-old woman with no significant medical history was referred with stabbing pain in right hip joint. The pain occurred during load-bearing activities such as walking for 4 months, and became worse even after taking medicine. (A) X-ray shows a well-defined intramedullary lesion, 5.6 × 3.3 × 2.5 cm in size. (B) CT scan highlighted cortical destruction. (C) T2-weighted axial MR image reveals focal cortical destruction with thinning and endosteal erosion (arrow) in the anterior aspect of the femur. (D) Fat-saturated T2-weighted coronal MR image reveals a well-defined intramedullary lesion with peritumoral bone edema (arrow) in the meta-diaphysis of the femur. (E) Gadolinium-enhanced T1-weighted coronal MR image reveals heterogenous enhancement. (F) CT-guided bone biopsy was performed because pain and radiographic finding of cortical thinning were atypical features for fibrous dysplasia and suggested the possibility of malignancy. The first biopsy specimen includes mainly blood clots with some bland-looking spindle cells and woven bone. (G) The second biopsy reveals atypical spindle cells with moderate-to-high cellularity and frequent mitotic figures.
Figure 1

Fibrous dysplasia (FD) is a benign fibro-osseous lesion with varying proportions of fibrous and osseous components. Depending on whether FD affects one or multiple bones, it is divided into monostotic and polyostotic types [1]. The craniofacial bones and femur are commonly involved in monostotic FD [2]. Malignant transformation of FD rarely occurs, and osteosarcoma (OS) is the most common histological subtype [3,4]. To date, there have been few reports demonstrating the molecular profiles of OS in FD [5]. Herein, we describe the clinicopathological, immunohistochemical, and molecular features of OS arising from FD of the proximal femur in a middle-aged woman. A detailed case presentation is presented in Figure 1 and Figure 2. As the degree of nuclear atypia and tumor cellularity in the outer portion suggested high-grade OS, we considered dedifferentiated low-grade central osteosarcoma (LGCOS) and OS arising in FD as the main differential diagnoses. LGCOS can be differentiated from FD by the presence of the following histologic features: infiltrative growth, cellularity, cytologic atypia, and mitotic activity [6,7]. Infiltrative growth, such as permeation or extension to the cortical bone and adjacent soft tissue, is an important gross feature of LGCOS. Microscopically, increased cellularity and intersecting fascicular patterns of spindle cells are usually detected in LGCOS but not in FD. LGCOS shows focal nuclear atypia, including hyperchromatic, enlarged nuclei, and irregular nuclear membranes. In addition to the morphological features, investigation of the underlying molecular profiles is helpful for differential diagnosis. While FD frequently harbors GNAS mutations [8,9], LGCOS frequently shows MDM2 and/or CDK4 amplification [10]. We conducted next-generation sequencing (NGS) analysis to determine whether the high-grade OS was dedifferentiation from LGCOS or malignant transformation from FD. DNA sequence-change analysis revealed GNAS (p.R201H, c.602G > A) and TP53 mutations (p.W53Cfs*70, c.159delG). Copy number variation analysis revealed a gain of PDGFRA, KIT, and CTNND2 and a loss of CDKN2A. TP53 mutations and CDKN2A deletions have been reported in primary OS or secondary OS associated with FD [5,11]. Our NGS results strongly supported the diagnosis of malignant transformation of FD. Following surgical resection and pathological diagnosis, the patient underwent Adriamycin-based chemotherapy and was alive without evidence of disease recurrence for 6 months. This case highlights the macroscopic, microscopic, and molecular characteristics of the malignant transformation of FD into OS. The diagnostic approaches, characteristic images, and interpretations of ancillary tests demonstrated in this case would help pathologists and clinicians make accurate diagnoses of malignant transformation of FD and their differential diagnosis from dedifferentiated LGCOS, which is essential for establishing an optimal treatment plan. A 38-year-old woman with no significant medical history was referred with stabbing pain in right hip joint. The pain occurred during load-bearing activities such as walking for 4 months, and became worse even after taking medicine. (A) X-ray shows a well-defined intramedullary lesion, 5.6 × 3.3 × 2.5 cm in size. (B) CT scan highlighted cortical destruction. (C) T2-weighted axial MR image reveals focal cortical destruction with thinning and endosteal erosion (arrow) in the anterior aspect of the femur. (D) Fat-saturated T2-weighted coronal MR image reveals a well-defined intramedullary lesion with peritumoral bone edema (arrow) in the meta-diaphysis of the femur. (E) Gadolinium-enhanced T1-weighted coronal MR image reveals heterogenous enhancement. (F) CT-guided bone biopsy was performed because pain and radiographic finding of cortical thinning were atypical features for fibrous dysplasia and suggested the possibility of malignancy. The first biopsy specimen includes mainly blood clots with some bland-looking spindle cells and woven bone. (G) The second biopsy reveals atypical spindle cells with moderate-to-high cellularity and frequent mitotic figures.

Figure 2

(A) Wide excision of proximal femur was performed. (B) Grossly, fibrous dysplasia portion is seen as a well-demarcated tan-gray mass with hard texture in the metaphysis of the femur (blue arrow). The osteosarcoma portion of the mass shows gray myxoid discoloration and fragile texture (red arrow). This portion was contiguous with cortical bone destruction and periosteal soft-tissue extension. (C) On low magnification, the tumors consist of an inner loosely cellular portion containing woven bone (right) and an outer highly cellular portion without woven bone (left). (D) The tumors destroyed the cortical bone and extended into the skeletal muscle. (E) On high magnification, the inner part of the tumor consists of curvilinear woven bone and fibrous stroma with bland spindle cells. (F) The outer part of the tumor shows highly cellular proliferation of pleomorphic cells with irregularly shaped hyperchromatic nuclei. Malignant osteoid interlaced the tumor cells. (G) SATB2 immunostaining demonstrates diffuse nuclear positivity. (H) CDK4 immunostaining shows negative result, suggesting a lack of MDM2 and/or CDK4 amplification.

(A) Wide excision of proximal femur was performed. (B) Grossly, fibrous dysplasia portion is seen as a well-demarcated tan-gray mass with hard texture in the metaphysis of the femur (blue arrow). The osteosarcoma portion of the mass shows gray myxoid discoloration and fragile texture (red arrow). This portion was contiguous with cortical bone destruction and periosteal soft-tissue extension. (C) On low magnification, the tumors consist of an inner loosely cellular portion containing woven bone (right) and an outer highly cellular portion without woven bone (left). (D) The tumors destroyed the cortical bone and extended into the skeletal muscle. (E) On high magnification, the inner part of the tumor consists of curvilinear woven bone and fibrous stroma with bland spindle cells. (F) The outer part of the tumor shows highly cellular proliferation of pleomorphic cells with irregularly shaped hyperchromatic nuclei. Malignant osteoid interlaced the tumor cells. (G) SATB2 immunostaining demonstrates diffuse nuclear positivity. (H) CDK4 immunostaining shows negative result, suggesting a lack of MDM2 and/or CDK4 amplification.
  9 in total

Review 1.  Malignant transformation of craniofacial fibrous dysplasia: a systematic review of overall survival.

Authors:  Zhi Li; Zijuan Wang; Haiyan Qian
Journal:  Neurosurg Rev       Date:  2019-02-27       Impact factor: 3.042

2.  Genome-Informed Targeted Therapy for Osteosarcoma.

Authors:  Leanne C Sayles; Marcus R Breese; Amanda L Koehne; Stanley G Leung; Alex G Lee; Heng-Yi Liu; Aviv Spillinger; Avanthi T Shah; Bogdan Tanasa; Krystal Straessler; Florette K Hazard; Sheri L Spunt; Neyssa Marina; Grace E Kim; Soo-Jin Cho; Raffi S Avedian; David G Mohler; Mi-Ok Kim; Steven G DuBois; Douglas S Hawkins; E Alejandro Sweet-Cordero
Journal:  Cancer Discov       Date:  2018-09-28       Impact factor: 39.397

3.  Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions.

Authors:  Flore Tabareau-Delalande; Christine Collin; Anne Gomez-Brouchet; Anne-Valérie Decouvelaere; Corinne Bouvier; Frédérique Larousserie; Béatrice Marie; Christophe Delfour; Sébastien Aubert; Philippe Rosset; Anne de Muret; Jean-Christophe Pagès; Gonzague de Pinieux
Journal:  Mod Pathol       Date:  2013-02-01       Impact factor: 7.842

4.  Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.

Authors:  Yoshiya Sugiura; Hiroaki Kanda; Noriko Motoi; Kimie Nomura; Kentaro Inamura; Erina Okada; Haruna Matsumoto; Takashi Shimoji; Seiichi Matsumoto; Jun Nakayama; Yutaka Takazawa; Yuichi Ishikawa; Rikuo Machinami
Journal:  Pathol Res Pract       Date:  2017-11-12       Impact factor: 3.250

5.  GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.

Authors:  Carolina Salinas-Souza; Carlos De Andrea; Michel Bihl; Michal Kovac; Nischalan Pillay; Tim Forshew; Alice Gutteridge; Hongtao Ye; M Fernanda Amary; Roberto Tirabosco; Silvia Regina Caminada Toledo; Daniel Baumhoer; Adrienne M Flanagan
Journal:  Mod Pathol       Date:  2015-08-07       Impact factor: 7.842

6.  Malignancies in fibrous dysplasia.

Authors:  P Ruggieri; F H Sim; J R Bond; K K Unni
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

Review 7.  Diagnostic challenges of low-grade central osteosarcoma of jaw: a literature review.

Authors:  Seyd Hosein Tabatabaei; Gholamreza Jahanshahi; Farzad Dehghan Marvasti
Journal:  J Dent (Shiraz)       Date:  2015-06

Review 8.  MDM2 Amplified Sarcomas: A Literature Review.

Authors:  Raf Sciot
Journal:  Diagnostics (Basel)       Date:  2021-03-11

9.  Clinicopathological and genetic study of a rare occurrence: Malignant transformation of fibrous dysplasia of the jaws.

Authors:  Ruirui Shi; Xuefen Li; Jianyun Zhang; Feng Chen; Ming Ma; Yanrui Feng; Tiejun Li
Journal:  Mol Genet Genomic Med       Date:  2022-01-05       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.